Table 2.
Diabetes and schizophrenia patients | Diabetes related ED visits |
Mental health related ED visits |
All other cause ED visits |
|||
---|---|---|---|---|---|---|
n (%) | p | n (%) | p | n (%) | p | |
Age | ||||||
18-29 (n = 1565) | 277 (17.7) | <.01 | 552 (35.3) | <.01 | 1314 (84.0) | <0.01 |
30-44 (n = 6138) | 1108 (18.1) | 1763 (28.7) | 5019 (81.8) | |||
45-64 (n = 16 210) | 2587 (16.0) | 3301 (20.4) | 12 833 (79.2) | |||
Race/ethnicity | ||||||
White (n = 8987) | 1403 (156) | <.01 | 2455 (27.3) | <.01 | 7374 (82.1) | <.01 |
Black (n = 10 413) | 1957 (18.9) | 2363 (27.3) | 8375 (80.4) | |||
Hispanic (n = 2455) | 281 (11.5) | 415 (16.9) | 1828 (74.5) | |||
Asian (n = 131) | 18 (13.7) | 26 (19.9) | 87 (66.4) | |||
Other (n = 1927) | 313 (16.2) | 357 (18.5) | 1502 (77.9) | |||
Gender | ||||||
Female (n = 15 464) | 2613 (16.9) | 0.11 | 3705 (24.0) | 0.02 | 12836 (83.0) | <.01 |
Male (n = 8448) | 1359 (16.1) | 1911 (22.6) | 6329 (74.9) | |||
Rural/urban status | ||||||
>1 million (metro area) (n = 6528) | 1145 (17.5) | .01 | 1737 (26.6) | <.01 | 5316 (81.4) | <.01 |
250 000-1 million (small metro area) (n = 8204) | 1376 (16.8) | 1898 (23 1) | 6568 (80.1) | |||
<250 000 (rural area) (n = 9181) | 1451 (15.8) | 1981 (21.6) | 7282 (79.3) | |||
Treatment | ||||||
Atypical antipsychotics (n = 13910) | 2155 (15.5) | <.01 | 2813 (20.2) | <.01 | 10918 (78.5) | <.01 |
Typical antipsychotics (n = 1843) | 294 (16.0) | 253 (13.7) | 1327 (72.0) | |||
Both (n = 6188) | 1149 (18.6) | 2214 (35.8) | 5295 (85.6) | |||
None (n = 1972) | 374 (19.0) | 336 (17.0) | 1626 (82.5) | |||
Elixhauser comorbidity index | ||||||
0 (n = 6362) | 562 (8.8) | <.01 | 548 (8.6) | <.01 | 3738 (58.8) | <.01 |
1-3 (n = 4316) | 637 (14.8) | 753 (17.5) | 3384 (78.4) | |||
4-5 (n = 2010) | 311 (15.5) | 458 (22.8) | 1718 (85.5) | |||
6-8 (n = 2171) | 374 (17.2) | 565 (26.0) | 1893 (87.2) | |||
>9 (n = 9054) | 2087 (23.1) | 3292 (36.4) | 8433 (93.1) |